Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific chi phí R&D phân khúc (Segment R&D Expense — ASU 2023-07) — Laboratory Products & Biopharma Services ($M)
SEC 10-K / 10-Q Note 11 (ASU 2023-07 Segment Disaggregation)
Latest, FY2025
56
Period ended Dec 31, 2025
Change on a year earlier
-15.2%
66 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Chi phí R&D phân khúc (Segment R&D Expense — ASU 2023-07) — Laboratory Products & Biopharma Services ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56 | -15.2% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 66 | -2.9% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 68 | -20.0% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 85 | – | SEC Form 10-K (10k_2024, filed 2025-02-20) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Chi phí R&D phân khúc (Segment R&D Expense — ASU 2023-07) — Laboratory Products & Biopharma Services ($M), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_rd_lpbs
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.